Effect of combination therapy with thyroxine (T4) and 3,5,3'-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study

Birte Nygaard, Ebbe Winther Jensen, Jan Kvetny, Anne Jarløv, Jens Faber

    116 Citations (Scopus)

    Abstract

    Treatment of hypothyroidism with 3,5,3'-triiodothyronine (T(3)) is controversial. A recent meta-analysis concludes that no evidence is present in favour of using T(3). However, the analysis included a mixture of different patient groups and dose-regimens.
    Original languageEnglish
    JournalEuropean Journal of Endocrinology
    Volume161
    Issue number6
    Pages (from-to)895-902
    Number of pages8
    ISSN0804-4643
    DOIs
    Publication statusPublished - 2009

    Keywords

    • Adolescent
    • Adult
    • Aged
    • Antithyroid Agents
    • Cross-Over Studies
    • Depression
    • Drug Therapy, Combination
    • Female
    • Humans
    • Hypothyroidism
    • Male
    • Middle Aged
    • Quality of Life
    • Thyrotropin
    • Thyroxine
    • Triiodothyronine

    Fingerprint

    Dive into the research topics of 'Effect of combination therapy with thyroxine (T4) and 3,5,3'-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study'. Together they form a unique fingerprint.

    Cite this